ArticleChemistry, an Asian journal2026
Photo-Enhanced Nicotine Release From Photosensitive Flavopeptide Derived Supramolecular Gel.
Article in Chemistry, an Asian journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Herein, we report the design and synthesis of a peptide-conjugated flavin analogue as a novel gelator material for photo-enhanced drug release. Harnessing the photosensitivity of the flavin entity was envisaged as a photo-trigger for faster drug release. Structural modification incorporating a dipeptide motif was undertaken to form a stable gel, which is characterized by field emission scanning electron microscopy (FE-SEM), rheology, thermo-gravimetric analysis (TGA), FT-IR, etc. Furthermore, the release of nicotine from the gel was evaluated in the presence of blue LED irradiation, which revealed a faster release of nicotine compared to the absence of a light trigger. This work reflects the potential of light-triggered drug delivery as a promising approach for controlled and enhanced drug release.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.